Surat utang korporasi
Berikut adalah daftar obligasi Novo Nordisk A/S Class B, diurutkan berdasarkan imbal hasil hingga jatuh tempo. Investor sering memilih obligasi perusahaan karena stabilitasnya yang lebih tinggi saat terjadi volatilitas di pasar. Pelajari harga, imbal hasil, dan statistik lainnya untuk menemukan investasi yang andal.
Simbol | YTM % | Volume | Harga % | Kupon % | Tanggal Jatuh Tempo | Jumlah yang belum dibayar | Nilai nominal | Jumlah denominasi minimum | Penerbit |
|---|---|---|---|---|---|---|---|---|---|
| XXS323295972Novo Nordisk Finance (Netherlands) BV 4.0% 20-NOV-2045 | 4,26% | 0 | 96,53% | 4,000% | 2045-11-20 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323295590Novo Nordisk Finance (Netherlands) BV 3.625% 20-FEB-2038 | 3,81% | 0 | 98,18% | 3,625% | 2038-02-20 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255582Novo Nordisk Finance (Netherlands) BV 3.625% 27-MAY-2037 | 3,73% | 0 | 98,96% | 3,625% | 2037-05-27 | 1,25 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323294453Novo Nordisk Finance (Netherlands) BV 3.375% 20-FEB-2035 | 3,56% | 0 | 98,57% | 3,375% | 2035-02-20 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282046075Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2034 | 3,47% | 0 | 99,26% | 3,375% | 2034-05-21 | 1,35 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255353Novo Nordisk Finance (Netherlands) BV 3.125% 27-MAY-2033 | 3,29% | 0 | 98,93% | 3,125% | 2033-05-27 | 900 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323293716Novo Nordisk Finance (Netherlands) BV 3.0% 20-FEB-2032 | 3,15% | 0 | 99,17% | 3,000% | 2032-02-20 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282045567Novo Nordisk Finance (Netherlands) BV 3.25% 21-JAN-2031 | 3,06% | 0 | 100,89% | 3,250% | 2031-01-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255329Novo Nordisk Finance (Netherlands) BV 2.875% 27-AUG-2030 | 3,00% | 0 | 99,43% | 2,875% | 2030-08-27 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
 XS244124704Novo Nordisk Finance (Netherlands) BV 1.375% 31-MAR-2030 | 2,89% | 0 | 94,02% | 1,375% | 2030-03-31 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255299Novo Nordisk Finance (Netherlands) BV 2.375% 27-MAY-2028 | 2,74% | 0 | 99,16% | 2,375% | 2028-05-27 | 1,45 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282045460Novo Nordisk Finance (Netherlands) BV 3.125% 21-JAN-2029 | 2,67% | 0 | 101,30% | 3,125% | 2029-01-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323292124Novo Nordisk Finance (Netherlands) BV 2.5% 20-FEB-2029 | 2,66% | 0 | 99,53% | 2,500% | 2029-02-20 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282044994Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2026 | 2,61% | 0 | 100,28% | 3,375% | 2026-05-21 | 1,3 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XS234803042Novo Nordisk Finance (Netherlands) BV 0.125% 04-JUN-2028 | 2,56% | 0 | 94,33% | 0,125% | 2028-06-04 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XS244933017Novo Nordisk Finance (Netherlands) BV 1.125% 30-SEP-2027 | 2,39% | 0 | 97,86% | 1,125% | 2027-09-30 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323292027Novo Nordisk Finance (Netherlands) BV FRN 20-NOV-2027 | — | 0 | 100,01% | 2,251% | 2027-11-20 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255213Novo Nordisk Finance (Netherlands) BV FRN 27-MAY-2027 | — | 0 | 99,76% | 2,366% | 2027-05-27 | 1,4 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |